merck ends trial of intercell's mrsa vaccine
u.s. drugmaker merck &amp; co  is to discontinue a major trial of a key vaccine from intercell  designed to protect against serious hospital infections, the austrian biotech firm said on wednesday.
http://feeds.reuters.com/~r/reuters/businessnews/~3/e_5kaizbmga/us-intercell-merck-idustre75711p20110608
26633
08 Jun 2011 12:45:44
reuters
business